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Different solvent extracts of Pleurotus giganteus fruiting bodies were tested for antifungal activities against Candida species responsible for human infections. 
The lipids extracted from the ethyl acetate fraction significantly inhibited the growth of all the Candida species tested. Analysis by GC/MS revealed lipid 
components such as fatty acids, fatty acid methyl esters, ergosterol, and ergosterol derivatives. The sample with high amounts of fatty acid methyl esters was 
the most effective antifungal agent. The samples were not cytotoxic to a mammalian cell line, mouse embryonic fibroblasts BALB/c 3T3 clone A31. To our 
knowledge, this is the first report of antifungal activity of the lipid components of Pleurotus giganteus against Candida species. 
 
Keywords:  Pleurotus giganteus, Candida, yeast, Antifungal, Medicinal mushroom, Fatty acid, Fatty ester methyl ester, Ergosterol. 
 
 
 
Fungal infections are problematic for human health and are 
responsible for high rates of morbidity and mortality worldwide. 
Species of Candida are the dominant cause of opportunistic 
mycoses and among them, C. albicans, C. glabrata, C. parapsilosis, 
C. tropicalis and C. krusei account for 95–97% of all Candida 
infections [1,2]. C. albicans and C. tropicalis are susceptible to 
polyenes, flucytosine, azoles and echinocandins, while C. glabrata 
is either susceptible or resistant to fluconazole[3]. Furthermore, C. 
krusei displays decreased susceptibility to amphotericin B, as well 
as fluconazole. Considering the increasing incidence of drug-
resistant Candida infections, the search for more effective anti-
Candida agents as an alternative to synthetic ones is needed. The 
interest in natural products from medicinal plants as a source of 
anti-Candida agents has grown dramatically. A wide variety of plant 
extracts have been reported to have anti-C. albicans activity. 
Examples include propolis, Punica granatum (pomegranate), 
Streblus asper (Siamese rough bush), Vitis vinifera (common grape 
vine), and tea tree oil from Melaleuca alternifolia [4].  
 
Medicinal mushrooms are relatively less researched for their 
antifungal properties. However, in the last five years, there has been 
a renewed interest in using mushrooms as antimicrobial agents. 
Lentinula edodes (shiitake), Boletus edulis (Penny bun), Pleurotus 
ostreatus (oyster mushroom), Coprinus comatus (shaggy mane), 
Astraeus hygrometricus (earthstar mushroom), and Cordyceps 
militaris were shown to exhibit antifungal activity against C. 
albicans [5–8]. Pleurotus giganteus (Zhudugu, Dabeijun, morning 
glory mushroom), a saprobic mushroom,  is one of the largest 
mushroom which grows on soil either as solitary or gregarious 
fruiting bodies [9]. This mushroom has gained popularity in China 
for its culinary properties. The medicinal properties of this 
mushroom are less known. We have previously reported the 
hepatoprotective and neuronal stimulating effects of P. giganteus 
[10,11]. In this study the antifungal activities of different solvent 
extracts of this mushroom were evaluated. The  extracts prepared 
with different solvents had different profiles of fatty acids, and fatty  
Table 1: Activity of different extracts of Pleurotus giganteus against Candida species. 
 
Candida strains Untreated
Solvent extracts (µg/mL) 
Methanol Ethyl acetate Aqueous 
25 50 100 25 50 100 25 50 100 
Candida albicans WM1172 ++++ ++++ +++ ++ + - - ++++ ++++ ++++
Candida albicans 
ATCC90028 ++++ +++ +++ + + - - ++++ ++++ +++
Candida dubliniensis ++++ ++++ +++ - + - - ++++ ++++ +++
Candida glabrata CBS138 ++++ ++++ ++ - + - - ++++ ++++ ++++
Candida glabrata 
ATCC90030 ++++ ++++ ++++ - + - - ++ +++ +++
Candida krusei ATCC6258 ++++ +++ +++ + - - - ++++ +++ +++
Candida pseudotropicalis ++++ +++ +++ ++ - - - ++++ ++++ ++++
Candida tropicalis WM30 ++++ +++ ++++ ++ + - - ++++ ++++ ++++
Strains were grown with different mushroom extracts at the concentrations shown for 
two days on YEPD media. Growth was scored from “-” to “++++”, indicating no 
growth to strong growth.  
 
acids have been shown to demonstrate antimicrobial activities 
[12].The main metabolites / components in the extracts were 
analysed by GC-MS. As a preliminary in vitro toxicity assessment, 
the P. giganteus extracts were also investigated for cytotoxicity to 
mouse embryonic 3T3 fibroblast cells. 
 
The anti-Candida activity of methanol, ethyl acetate and aqueous 
extracts of P. giganteus against all yeast species tested are 
summarised in Table 1. Candida species showed strong growth 
(denoted as “++++”) when extracts were not added to the medium. 
The aqueous extract had minimum or no inhibitory activity against 
all Candida spp. The ethyl acetate extract completely inhibited the 
growth of all Candida spp. when tested at 50 and 100 µg/mL.  
Thus, the ethyl acetate extract was fractionated to identify the active 
component/s responsible for the antifungal activity. Sub-fractions A 
to H were obtained and the minimum inhibitory concentration 
(MIC) values against all the tested yeasts are given in Table 2.    
The MIC values for all the Candida spp. tested, ranged from 2.0 ± 
1.0 to 10.3 ± 2.5 µg/mL for sub-fraction A; and 9.3 ± 2.3 to 34.3 ± 
10.8 µg/mL for  sub-fraction  B;  respectively.  The  MIC  values of  
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Table 2: Activity of the sub-fractions of ethyl acetate extracts against Candida species. 
 
Candida strains 
Sub-fractions from ethyl acetate 
extract (MICa) 
IC50 (mM) 
A B C D E F G H Fluconazole
Amphotericin 
B 
Candida albicans 
WM1172 
7.3 ± 
1.5 
16.0 ± 
6.1 
26.6 ± 
11.6 * * * * * 1.0 0.6 
Candida albicans 
ATCC90028 
7.0 ± 
1.0 
22.6 ± 
11.5 
40.6 ± 
16.6 * * * * * 2.0 0.7 
Candida dubliniensis 8.2 ± 
3.7 
31.6 ± 
7.8 
37.0 ± 
7.0 * * * * * 24.0 2.1 
Candida glabrata 
CBS138 
8.1 ± 
1.5 
12.5 ± 
2.4 
28.3 ± 
6.6 * * * * * >10.0 1.3 
Candida glabrata 
ATCC90030 
9.2 ± 
1.6 
29.4 ± 
7.0 
41.3 ± 
7.6 * * * * * >10.0 1.2 
Candida krusei 
ATCC6258 
10.3 ± 
2.5 
37.2 ± 
5.0 * * * * * * 8.0 0.4 
Candida 
pseudotropicalis 
3.8± 
1.4 
9. 3 ± 
2.3 
23.0 ± 
11.0 * * * * * 9.0 0.6 
Candida tropicalis 
WM30 
2.0 ± 
1.0 
34.3 ± 
10.8 * * * * * * <1.0 1.2 
Results were from three independent experiments performed in triplicate. aMIC is 
expressed in µg/mL. * : >50 µg/mL 
 
sub- fraction C varied from 23.0 ± 11.0 to >50 µg/mL; whereas the 
MIC values for sub-fractions D-H were all >50 µg/mL. Overall, 
sub-fraction A showed the lowest MIC value for all Candida spp. 
tested.  
 
Sub-fractions A and B were further analysed by GC-MS. Both 
samples were pale yellow-colored oils with a distinct odor. 
Constituents of sub-fractions A and B are listed in Table 3. Twelve 
compounds were identified in sub-fractions A and B. Sample A was 
characterized by high amounts of fatty acid methyl esters, namely: 
methyl palmitate, ethyl palmitate, methyl linoleate, methyl oleate, 
methyl stearate, and ethyl oleate. Sample B contained fatty acids 
(palmitic acid and oleic acid), fatty acid methyl esters (methyl 
linoleate and methyl oleate), ergosterol, ergosta-5,7,9 (11),22-
tetraen-3β-ol, ergost-5,8(14)-dien-3-ol, and γ-ergostenol.  
 
Table 3: Chemical composition of lipids in sub-fractions A and B of .P. giganteus. 
 
Constituents RT (min) Percentage (%) Quality 
Sub-fraction A    
Methyl palmitate 20.50 14.8 99 
Ethyl palmitate 21.81 1.2 98 
Methyl linoleate 23.70 19.8 99 
Methyl oleate 23.80 39.3 99 
Methyl stearate  24.26 3.3 99 
Ethyl oleate  24.99 12.3 99 
Sub-fraction B    
Methyl palmitate 20.49 0.2 95 
Palmitic acid  21.28 14.4 99 
Methyl linoleate 23.68 0.4 93 
Methyl oleate 23.79 1.0 93 
Oleic acid  24.61 31.7 99 
Ergosta-5,7,9(11),22-tetraen-3β-ol  39.83 2.2 90 
Ergosterol  40.33 24.4 98 
Ergost-5,8(14)-dien-3-ol 40.51 10.2 87 
γ-Ergostenol 41.32 3.7 94 
 
The methanol, ethyl acetate, and aqueous extracts were not toxic to 
3T3 fibroblasts cells and the IC50 values were more than 2 mg/mL 
(Fig. 1). Meanwhile, cell viability (%) decreased steadily with 
increasing concentrations of sub-fractions A and B at levels up to 
500 µg/mL. The IC50 value of sub-fraction A was 352 µg/mL and 
the R2 value was 0.9609. For sub-fraction B, the IC50 was 362 
µg/mL with the R2 value recorded at 0.9552. 
 
To our knowledge, this is the first report on the antifungal activity 
of the lipid components of P. giganteus. It has been reported that 
crude extracts of P. ostreatus and C. comatus inhibited the growth 
of C. albicans [6]. However, the MICs were much higher (up to 1 
mg/mL) when compared with this study, which recorded an MIC of  
 
 
Figure 1: Cell viability of embryonic fibroblast cells after treatment with various 
extracts of P. giganteus. 
 
100 µg/mL. The sub-fractions A and B were shown to contain 
several bioactive components. Since they are blends of fatty acids 
and fatty acid methyl esters, they do not act on specific targets in 
the fungal cells, and fungal resistance may be unlikely to occur. 
Furthermore, fatty acids and their methyl esters were reported to 
have fungicidal activity to C. albicans, C. krusei, C. tropicalis and 
C. parapsilosis [13]. The entities might play crucial roles in 
lipophilic or hydrophilic effects on the cell wall and membrane, 
hence affecting the distribution of the lipids in the cells [14]. 
Moreover, ergosterol present in the sample could disrupt the 
ergosterol biosynthesis pathway in the yeast, causing growth 
inhibition or cell death. This was further supported by a study of 
Irshad et al. [15], who reported that ergosterol-rich Cassia fistula oil 
significantly decreased the in vivo ergosterol content in the Candida 
cell wall. 
 
In this study, the sub-fractions A and B were not cytotoxic to mouse 
fibroblasts at the concentrations tested (Fig. 1).  Animal testing is 
becoming less popular and is gradually being replaced by in vitro 
methods for toxicity assessment of pharmaceutical products. In 
conclusion, P. giganteus lipids are promising natural products to be 
further explored as antifungal agents against Candida species.  
 
Experimental 
 
Mushroom: The fruiting bodies of Pleurotus giganteus (Berk) 
Karunarathna & K.D. Hyde were obtained from Nas Agro Farm, 
Selangor, Malaysia. A voucher specimen (KLU-M 1227) was 
deposited in the Herbarium in the University of Malaya. 
 
Chemicals: Fluconazole and amphotericin B were purchased from 
Sigma Co. (St. Louis, MO, USA). The stocks were prepared in 
dimethyl sulfoxide (DMSO) prior to bioassays. [3-(4,5-
Dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT), 
was also obtained from Sigma. Methanol (MeOH), ethyl acetate 
(EtOAc), n-hexane and acetone were from Merck (Darmstadt, 
Germany). 
 
Extracts preparation: The fresh fruiting bodies of P. giganteus 
were sliced, freeze-dried and ground to a fine powder (500 g). The 
mushroom powder was extracted with 80% MeOH to yield a MeOH 
extract (115 g, 23.0%). This (125 g) was further partitioned in 
EtOAc-H2O (100 mL: 100 mL) to give an EtOAc-soluble extract 
(6.96 g, 6.05%) and a H2O extract (74.2 g, 64.52%).  
 
Fractionation of extract: The EtOAc extract (5.00 g) was further 
fractionated by CC over silica gel. The extract was eluted with n-
hexane containing increasing concentrations of acetone to obtain 8 
fractions (A to H) based on similarity of spots on TLC.  
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Cell culture: Mouse embryonic fibroblasts were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 
10%, v/v, heat-inactivated fetal bovine serum (PAA), 100 U/mL 
penicillin and 100 µg/mL streptomycin. The cells were routinely 
passaged every 2-3 days and incubated at 37°C and 5%, v/v, CO2 in 
a humidified atmosphere.  
 
Cytotoxicity: The crude MeOH and fractionated EtOAc extracts 
were dissolved in DMSO (10 mg/mL) as stock solutions. The H2O 
extract (10 mg/mL) was stocked in sterilised distilled water. The 
cytotoxic effects of varying concentrations of MeOH, EtOAc and 
H2O extracts, as well as the fractions A-H in DMSO to 3T3 
fibroblast cells were tested by the established colorimetric MTT 
assay [16]. The absorbance was measured at 550 nm using a 
microplate reader. The IC50 is the concentration of extract or 
fraction that reduced fibroblast cell growth by 50%. 
 
Anti-yeast activity: Candida albicans WM1172, C. albicans 
ATCC90028, C. dubliniensis, C. glabrata CBS138, C. glabrata 
ATCC90030, C. krusei ATCC6258, C. pseudotropicalis, and C. 
tropicalis WM30 were used in this study. The yeast inhibition assay 
was performed according to the method of Macreadie et al. [17]. 
The yeast strains were grown in YEPD (1% yeast extract, 2% 
peptone, 2% glucose). If required, media were solidified by the 
addition of 1.5% agar. Yeast inocula (100 µL) with a starting 
optical density at A595 of 0.02-0.04 were added to each well of a 96-
well microplate (Orange Scientific, Braine-l’Alleud, Belgium). 
Mushroom extracts were then added as two-fold serial dilutions 
commencing with a 100 µg/mL concentration. Fluconazole (0.1 
mM) and amphotericin B (1.0 mM) were used as positive controls. 
A growth control DMSO solvent alone was also included. The 
microplate was incubated in a microplate shaker at 35ºC. After 2 h 
and 4 h incubation, the A595 was recorded using a microplate reader 
(Sunrise™, Tecan, Austria). Each sample was assayed in triplicate. 
The lowest concentration of extracts that inhibited growth of 
Candida spp. is the minimum inhibitory concentration (MIC). 
 
Gas chromatography-mass spectrometry (GCMS): GCMS analysis 
was performed on sub-fractions A and B using Network Gas 
Chromatography system (Agilent Technologies 6890N) equipped 
with an Inert Mass Selective Detector (Agilent Technologies 5975) 
(70eV direct inlet) on a HP-5ms (5% phenyl methyl siloxane) 
capillary column (30 m × 250 µm × 0.25 µm) initially set at 150ºC, 
then increased at 5ºC per min to 300ºC and held for 10 min. Helium 
was used as carrier gas at a flow rate of 1 mL per min. The total ion 
chromatogram obtained was autointegrated by chemstation and the 
constituents were identified by comparison with the accompanying 
mass-spectra database (Wiley 9th edition with NIST 11 Mass 
Spectral Library, USA) wherever possible. 
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